Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
1 "Hirokazu Kanegane"
Filter
Filter
Article category
Publication year
Case Report
Miscellaneous
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
Haruka Miyazaki, Namiko Hoshi, Michitaka Kohashi, Eri Tokunaga, Yuna Ku, Haruka Takenaka, Makoto Ooi, Nobuyuki Yamamoto, Suguru Uemura, Noriyuki Nishimura, Kazumoto Iijima, Keisuke Jimbo, Tsubasa Okano, Akihiro Hoshino, Kohsuke Imai, Hirokazu Kanegane, Ichiro Kobayashi, Yuzo Kodama
Intest Res 2022;20(1):144-149.   Published online January 22, 2021
DOI: https://doi.org/10.5217/ir.2020.00041
AbstractAbstract PDFPubReaderePub
Autoimmune enteropathy (AIE) is a rare disease, characterized by intractable diarrhea, villous atrophy of the small intestine, and the presence of circulating anti-enterocyte autoantibodies. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome, and mutations in FOXP3, which is a master gene of regulatory T cells (Tregs), are major causes of AIE. Recent studies have demonstrated that mutations in other Treg-associated genes, such as CD25 and CTLA4, show an IPEX-like phenotype. We present the case of a 13-year-old girl with CTLA4 haploinsufficiency, suffering from recurrent immune thrombocytopenic purpura and intractable diarrhea. We detected an autoantibody to the AIE-related 75 kDa antigen (AIE-75), a hallmark of the IPEX syndrome, in her serum. She responded well to a medium dose of prednisolone and a controlled dose of 6-mercaptopurine (6-MP), even after the cessation of prednisolone administration. Serum levels of the soluble interleukin-2 receptor and immunoglobulin G (IgG) were useful in monitoring disease activity during 6-MP therapy. In conclusion, autoimmune-mediated mechanisms, similar to the IPEX syndrome, may be involved in the development of enteropathy in CTLA4 haploinsufficiency. Treatment with 6-MP and monitoring of disease activity using serum levels of soluble interleukin-2 receptor and IgG is suggested for such cases.

Citations

Citations to this article as recorded by  
  • Diagnostic clues in patients with clinical malabsorption and pathological small intestinal villous atrophy: Immune-mediated type and beyond
    Mu-Han Li, Qi-Pu Wang, Cheng-Zhu Ou, Tian-Ming Xu, Yang Chen, Hao Tang, Yan Zhang, Yan-Jun Lai, Xu-Zhen Qin, Ji Li, Wei-Xun Zhou, Jing-Nan Li
    World Journal of Gastroenterology.2026;[Epub]     CrossRef
  • Clinical and genetic features of CTLA-4 haploinsufficiency: a prospective study in China
    Guishan Liu, Jingyuan Zhang, Di Wu, Jin Xu, Jiayuan Dai, Min Shen
    BMC Rheumatology.2026;[Epub]     CrossRef
  • Pathological perspectives on immune-related adverse events
    Terufumi Kubo, Rena Morita, Kenta Sasaki, Naoki Shijubou, Kenji Murata, Tomohide Tsukahara, Toshihiko Torigoe, Yoshihiko Hirohashi
    Immunological Medicine.2026; : 1.     CrossRef
  • Advances and challenges in diagnosing and managing adult autoimmune enteropathy
    Grigorios Christodoulidis, Sara E Agko, Marina N Kouliou, Konstantinos E Koumarelas, Dimitris Zacharoulis
    World Journal of Gastroenterology.2025;[Epub]     CrossRef
  • Non-Celiac Villous Atrophy—A Problem Still Underestimated
    Katarzyna Napiórkowska-Baran, Paweł Treichel, Adam Wawrzeńczyk, Ewa Alska, Robert Zacniewski, Maciej Szota, Justyna Przybyszewska, Amanda Zoń, Zbigniew Bartuzi
    Life.2025; 15(7): 1098.     CrossRef
  • Engineering nanoparticle therapeutics for food allergy
    Laila M. Rad, Gabriel Arellano, Joseph R. Podojil, Jessica J. O’Konek, Lonnie D. Shea, Stephen D. Miller
    Journal of Allergy and Clinical Immunology.2024; 153(3): 549.     CrossRef
  • Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders
    Christopher Failing, Jennifer R. Blase, Kelly Walkovich
    Rheumatic Disease Clinics of North America.2023; 49(4): 841.     CrossRef
  • Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab
    Manuel A. Baarslag, Joosje H. Heimovaara, Jessica S.W. Borgers, Koen J. van Aerde, Hans J.P.M. Koenen, Ruben L. Smeets, Pauline L.M. Buitelaar, Dick Pluim, Shoko Vos, Stefanie S.V. Henriet, Jan Willem B. de Groot, Martine van Grotel, Hilde Rosing, Jos H.
    New England Journal of Medicine.2023; 389(19): 1790.     CrossRef
  • Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study
    Akihiro Hoshino, Etsushi Toyofuku, Noriko Mitsuiki, Motoi Yamashita, Keisuke Okamoto, Michio Yamamoto, Kenji Kanda, Genki Yamato, Dai Keino, Yuri Yoshimoto-Suzuki, Junji Kamizono, Yasuhiro Onoe, Takuya Ichimura, Mika Nagao, Masaru Yoshimura, Koji Tsugawa,
    Frontiers in Immunology.2022;[Epub]     CrossRef
  • Treg specialization and functions beyond immune suppression
    Jillian L Astarita, Claudia X Dominguez, Corey Tan, Jovanny Guillen, Mariela L Pauli, Rosario Labastida, Jose Valle, Melanie Kleinschek, Jesse Lyons, Ali A Zarrin
    Clinical and Experimental Immunology.2022;[Epub]     CrossRef
  • 12,578 View
  • 439 Download
  • 11 Web of Science
  • 10 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP